Revenue of $20 million is completely realistic imo.
Assuming hospitals need to reorder every quarter, that's approx $600k per hospital per annum.
Only 34 hospitals required to achieve those numbers. And that's assuming we're only talking revenue from the US, what about the rest of the globe?
Now that the cherry has been popped with 2 major US hospitals on board, the orders will start flowing.
Ann: Further US Sales for NovoSorb BTM, page-50
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.35 |
Change
0.020(0.86%) |
Mkt cap ! $1.623B | |||
| Open | High | Low | Value | Volume |
| $2.27 | $2.37 | $2.27 | $3.035M | 1.301M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 26580 | $2.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.37 | 12054 | 2 |
View Market Depth
| Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
| PNV (ASX) Chart |